Nomura Holdings Inc

Nomura Holdings Inc (NMR) Stock Analysis

$10.300

+0.183 (+1.78%)At close

Loading chart…
High
10.360
Open
10.290
VWAP
10.30
Vol
660.93K
Mkt Cap
16.96B
Low
10.240
Amount
6.81M
EV/EBITDA, TTM
38.82

Nomura Holdings Inc is a Japan-based company mainly engaged in the securities, investment, and other financial services business across the world. The Company has three business segments. The Sales segment provides investment consultation services to individual clients in Japan. The Investment Management segment provides investment management services and investment solutions, including the establishment and management of investment trusts, discretionary investment services for domestic and foreign investors, fund management and administration for investment corporations and institutional investors, and silent partnership management. The Wholesale segment is engaged in the sale and trading of bonds, equity securities, derivatives, and foreign exchange, as well as investment banking services such as the bonds and securities underwriting business, merger and acquisition (M&A) business and financial advisory services. The Company operates in Japan, the Americas, Europe, Asia and Oceania.

AI analysis of Nomura Holdings Inc (NMR)

buy

Nomura Holdings, Inc is a good buy right now due to its current price of $10.3, which is below the analyst price target of $10.20, indicating potential upside. The company has shown strong revenue growth with a gross margin of 47.59% in Q4 2026, reflecting its operational efficiency. However, the main risk is its high debt-to-equity ratio at 917.37%, which could impact financial stability.

Analyst Ratings (1)

Hold
0 Buy
1 Hold
0 Sell
Current: 10.30
Low
Average
High

BofA

2026-06-25

Price Target

Buy

JPMorgan

2026-03-19

Price Target

Overweight

JP Morgan

2024-08-29

Price Target

Hold

Jefferies

2023-01-25

Price Target

Hold

Goldman Sachs

2021-03-30

Price Target

Hold

Valuation Metrics

The current forward P/E ratio for Nomura Holdings Inc (NMR) is 15.38, compared to its 5-year average forward P/E of 10.46.

Forward P/E

Overvalued
5Y Average P/E
10.46
Current P/E
15.38
Overvalued
13.21
Undervalued
7.72

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
5.08
Current EV/EBITDA
38.82
Overvalued
18.58
Undervalued
-8.43

Forward P/S

Strongly Undervalued
5Y Average P/S
1.16
Current P/S
0.01
Overvalued
1.66
Undervalued
0.66

Alphio AI Price Scenarios for NMR

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%NMR

$16.30

Scenario price

B

Base

Base · 50%NMR

$13.53

Scenario price

B

Bear

Bear · 25%NMR

$10.96

Scenario price

NMR FAQ — answered by Alphio AI

Nomura Holdings Inc is a Japan-based company mainly engaged in the securities, investment, and other financial services business across the world. The Company has three business segments. The Sales segment provides investment consultation services to individual clients in Japan. The Investment Management segment provides investment management services and investment solutions, including the establishment and management of investment trusts, discretionary investment services for domestic and foreign investors, fund management and administration for investment corporations and institutional investors, and silent partnership management. The Wholesale segment is engaged in the sale and trading of bonds, equity securities, derivatives, and foreign exchange, as well as investment banking services such as the bonds and securities underwriting business, merger and acquisition (M&A) business and financial advisory services. The Company operates in Japan, the Americas, Europe, Asia and Oceania. It operates in the Financials sector (SECURITY BROKERS, DEALERS, AND FLOTATION COMPANIES industry).

Nomura Holdings, Inc is a good buy right now due to its current price of $10.3, which is below the analyst price target of $10.20, indicating potential upside. The company has shown strong revenue growth with a gross margin of 47.59% in Q4 2026, reflecting its operational efficiency. However, the main risk is its high debt-to-equity ratio at 917.37%, which could impact financial stability.

1 analysts cover NMR: 0 rate it Buy, 1 Hold and 0 Sell.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始